Construct validity of the IDEOM MSK Questionnaire (IDEOM MSK-Q): an instrument to measure musculoskeletal symptoms in patients with psoriatic disease

By sjmartinez • January 27, 2025

Perez-Chada LM, Gondo G, Grant C, Woodbury M, Kucharik AH, Armstrong AW, Eder L, Mease P, Ogdie A, Strand V, Gottlieb AB, Merola JF. Construct validity of the IDEOM MSK Questionnaire (IDEOM MSK-Q): an instrument to measure musculoskeletal symptoms in patients with psoriatic disease. J Invest Dermatol. 2025 Jan 24:S0022-202X(25)00035-1. doi: 10.1016/j.jid.2024.10.619. Epub ahead of print. PMID: 39864735.

Tags: Dermatology, IDEOM, Musculoskeletal, outcome measure, psoriasis, psoriatic arthritis, Publications

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial

Mease PJ, Chandran V, Armstrong AW, Blanco R, Ogdie A, Siegel EL, Gottlieb AB, Zeng X, Thaçi D, Kishimoto M, Schulze-Koops H, Kivitz A, Dokoupilová[...]

ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype

Assan F, Tragin M, Marella S, Lipecka J, Roger K, Zarhrate M, Bondet V, Nguyen V, Akroun F, Nitschké P, Guerrera IC, Bole C, Izmiryan[...]

A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score

Cortes JA, Aflatooni S, Ure A, Palma G, Johnsen N, Smart K, Nong Y, Armstrong AW. A practical inflammatory blood-cell marker for cardiovascular risk stratification[...]